收费全文 | 85213篇 |
免费 | 8527篇 |
国内免费 | 159篇 |
医药卫生 | 93899篇 |
2021年 | 1135篇 |
2020年 | 823篇 |
2019年 | 1142篇 |
2018年 | 1479篇 |
2017年 | 1098篇 |
2016年 | 1184篇 |
2015年 | 1327篇 |
2014年 | 1715篇 |
2013年 | 2717篇 |
2012年 | 3490篇 |
2011年 | 3769篇 |
2010年 | 2084篇 |
2009年 | 2027篇 |
2008年 | 3278篇 |
2007年 | 3593篇 |
2006年 | 3480篇 |
2005年 | 3522篇 |
2004年 | 3287篇 |
2003年 | 3042篇 |
2002年 | 3035篇 |
2001年 | 2801篇 |
2000年 | 2878篇 |
1999年 | 2634篇 |
1998年 | 1219篇 |
1997年 | 1065篇 |
1996年 | 1065篇 |
1995年 | 903篇 |
1994年 | 857篇 |
1993年 | 854篇 |
1992年 | 2110篇 |
1991年 | 2028篇 |
1990年 | 1907篇 |
1989年 | 1884篇 |
1988年 | 1793篇 |
1987年 | 1796篇 |
1986年 | 1707篇 |
1985年 | 1681篇 |
1984年 | 1395篇 |
1983年 | 1269篇 |
1982年 | 851篇 |
1981年 | 728篇 |
1980年 | 643篇 |
1979年 | 1221篇 |
1978年 | 879篇 |
1977年 | 768篇 |
1976年 | 731篇 |
1975年 | 720篇 |
1974年 | 864篇 |
1973年 | 753篇 |
1972年 | 735篇 |
Background
We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.Methods
In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).Results
After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).Conclusions
This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy. 相似文献Main outcome measures In all subjects expiratory volumes were determined and urinary analysis was conducted for hydroxyproline, calcium, phosphorus, and cortisol levels. Osteocalcin, calcium, phosphorus, cortisol, alkaline phosphatase, and γ-glutamyltransferase levels were measured in blood samples. Bone density of the lumbar spine was determined by means of dual-energy x-ray absorptiometry. Nutrition evaluation was based on a 3-day food diary analyzed using progiciel Nutri 91. The nutritional parameters examined were calcium; phosphorus; magnesium; zinc; vitamins A, C, and D; protein; total fiber; oxalates; energy; caffeine; and alcohol in relation to bone density.
Subjects Thirty-one patients with moderate to severe asthma who had been taking more than 1,000 μg beclomethasone per day or the equivalent for more than 2 years and 27 patients with mild asthma who were taking less than 500 μg beclomethasone per day or the equivalent.
Statistical analyses performed Four factor analysis of variance with hierarchized interactions of four levels, Duncan's test, Pearson correlation coefficients.
Results Blood levels of osteocalcin and protein intake were lower in patients with moderate to severe asthma than in those with mild asthma (P<.05). Significant correlations (P<.02) were observed between bone density and calcium intake (r=.40), phosphorus intake (r=.35), protein intake (r=.30), and serum alkaline phosphatase level (r=−.30). Bone density was not significantly different between the two groups of patients with asthma.
Applications A follow-up of patients with asthma who are taking inhaled corticosteroids is needed to assess bone density, osteocalcin levels, and dietary intakes of calcium. Verify if osteocalcin level decreases over time in patients with moderate to severe asthma, monitor possible modifications in bone density, and verify if the correlation between dietary calcium and bone density is maintained. J Am Diet Assoc. 1997;97:1401–1406. 相似文献